Evidence map›Paper›PMID 29516036›Full record

ArticleeNeuro

Inhibition of a Descending Prefrontal Circuit Prevents Ketamine-Induced Stress Resilience in Females.

S D Dolzani, M V Baratta, J M Moss, N L Leslie, S G Tilden, A T Sørensen, L R Watkins, Y Lin, S F Maier

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. A Computational Model of Hopelessness and Active-Escape Bias in Suicidality.Computational psychiatry (Cambridge, Mass.) · 2022
    Article
  9. Review
  10. Acute (Frontiers in neuroscience · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

S D DolzaniDepartment of Psychology and Neuroscience and the Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309.ORCID 0000-0003-1279-0874
M V BarattaDepartment of Psychology and Neuroscience and the Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309.
J M MossDepartment of Psychology and Neuroscience and the Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309.ORCID 0000-0002-6714-9788
N L LeslieDepartment of Psychology and Neuroscience and the Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309.
S G TildenDepartment of Psychology and Neuroscience and the Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309.
A T SørensenDepartment of Neuroscience, University of Copenhagen, Copenhagen, 1165 Denmark.ORCID 0000-0001-5887-9247
L R WatkinsDepartment of Psychology and Neuroscience and the Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309.
Y LinMcGovern Institute for Brain Research, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139.
S F MaierDepartment of Psychology and Neuroscience and the Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309.
University of Colorado Boulder · USMcGovern Institute for Brain Research · USUniversity of Copenhagen · DK

Funding

Stressor Controllability: The Role of the mPFC in Producing ResiliencyR01MH050479 · NIMH · UNIVERSITY OF COLORADO AT BOULDER · PI MICHAEL V BARATTA, STEVEN F MAIER · 1993 to 2026
$7.9M
Research Training: Mental Health Behavior GeneticsT32MH016880 · NIMH · UNIVERSITY OF COLORADO AT BOULDER · PI Naomi P. Friedman, Matthew Charles Keller · 1985 to 2026
$5.3M
STRESSOR CONTROLLABILITY: ANXIETY AND SEROTONINR37MH050479 · NIMH · UNIVERSITY OF COLORADO AT BOULDER · PI MAIER, STEVEN F · 1997 to 2006
$2.3M
Embedded Prefrontal Circuits in Stress ResilienceR21MH106817 · NIMH · UNIVERSITY OF COLORADO · PI BARATTA, MICHAEL V, MAIER, STEVEN F · 2015 to 2016
$419k
NIMH NIH HHS R01 MH050479NIMH NIH HHS R21 MH106817NIMH NIH HHS R37 MH050479NIMH NIH HHS T32 MH016880
6 · The paper itself

Abstract

Stress is a potent etiological factor in the onset of major depressive disorder and posttraumatic stress disorder (PTSD). Therefore, significant efforts have been made to identify factors that produce resilience to the outcomes of a later stressor, in hopes of preventing untoward clinical outcomes. The NMDA receptor antagonist ketamine has recently emerged as a prophylactic capable of preventing neurochemical and behavioral outcomes of a future stressor. Despite promising results of preclinical studies performed in male rats, the effects of proactive ketamine in female rats remains unknown. This is alarming given that stress-related disorders affect females at nearly twice the rate of males. Here we explore the prophylactic effects of ketamine on stress-induced anxiety-like behavior and the neural circuit-level processes that mediate these effects in female rats. Ketamine given one week prior to an uncontrollable stressor (inescapable tailshock; IS) reduced typical stress-induced activation of the serotonergic (5-HT) dorsal raphe nucleus (DRN) and eliminated DRN-dependent juvenile social exploration (JSE) deficits 24 h after the stressor. Proactive ketamine altered prelimbic cortex (PL) neural ensembles so that a later experience with IS now activated these cells, which it ordinarily would not. Ketamine acutely activated a PL to DRN (PL-DRN) circuit and inhibition of this circuit with Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) at the time of IS one week later prevented stress prophylaxis, suggesting that persistent changes in PL-DRN circuit activity are responsible, at least in part, for mediating long-term effects associated with ketamine.

Indexed as

AnimalsAnxietyDorsal Raphe NucleusElectroshockExcitatory Amino Acid AntagonistsFemaleKetamineNeural PathwaysPrefrontal CortexRats, Sprague-DawleyResilience, PsychologicalSerotoninStress, PsychologicalExcitatory Amino Acid AntagonistsKetamineSerotonindorsal raphe nucleusketamineprefrontal cortexresilienceserotoninstress

Identifiers

PMID29516036
PMCPMC5839773
OpenAlexW2793182189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.